USE OF GLP-1 RECEPTOR AGONISTS IN THE TREATMENT OF OBESITY: CLINICAL EVIDENCE AND NUTRITIONAL IMPLICATIONS. REMUNOM [Internet]. 2025 Dec. 28 [cited 2026 Jan. 11];21(05):1-11. Available from: https://remunom.ojsbr.com/multidisciplinar/article/view/5181